Physician profile
Aaron J Overly
NPI 1861758880
$2,016.75
in general payments reported to CMS, 2019-2025
21 companies · $96.92 in 2025
The $96.92 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $910 · 2020: $112 · 2021: $220 · 2022: $299 · 2023: $320 · 2024: $58.61 · 2025: $96.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $834.13 | 2019-2022 | |
| Ethicon US, LLC | $151.96 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $138.92 | 2019-2022 | |
| Urgo Medical North America, LLC | $137.16 | 2023 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Leica Microsystems INC. | $134.56 | 2022 | |
| Sanara Medtech INC. | $127.66 | 2023 | Celleraterx |
| Endo Pharmaceuticals INC. | $80.19 | 2019-2021 | |
| Medtronic, INC. | $63.08 | 2021-2025 | Plasmablade(Tm) |
| Hologic Sales and Service, LLC | $45.80 | 2025 | Magseed, Sentimag, Magtrace |
| Braintree Laboratories, INC. | $41.06 | 2020-2021 | |
| Innocoll Pharmaceuticals Limited | $38.70 | 2022-2023 | Xaracoll |
| Janssen Biotech, INC. | $32.82 | 2023 | Erleada |
| Tela Bio, INC. | $30.57 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Convatec INC. | $27.38 | 2022 | |
| Smith+Nephew, INC. | $25.93 | 2024 | Grafix Pl |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $22.45 | 2020 | |
| Baxter Healthcare | $21.59 | 2019 | |
| Impedimed, INC. | $18.64 | 2024 | |
| Ferring Pharmaceuticals INC. | $16.73 | 2021 | |
| Tactile Systems Technology INC | $14.04 | 2024 | Flexitouch Plus, Entre Plus |
| Shire North American Group INC | $13.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Overly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.